カテゴリー： MarketsandMarkets, 世界, 医療/バイオ

血漿分画用コールドチェーン製品の世界市場予測（〜2027年）：種類別、エンドユーザー別

◆英語タイトル：Cold Chain Products Market for Plasma Fractionation by Type (Ultra-low temperature freezer, Plasma freezer, Temperature monitoring devices, Plasma contact shock freezer, Blood transport boxes, Ice-lined refrigerator), End User - Global Forecast to 2027

MarketsandMarketsが発行した調査報告書（MD8654-23）◆商品コード：MD8654-23
◆発行会社（リサーチ会社）：MarketsandMarkets
◆発行日：2023年5月22日
◆ページ数：186
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後24時間以内）
◆調査対象地域：グローバル
◆産業分野：医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧）USD4,950 ⇒換算￥752,400見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算￥1,010,800見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算￥1,238,800見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

MarketsandMarkets社の本調査レポートでは、世界の血漿分画用コールドチェーン製品市場規模が2022年の569百万ドルから2027年までに711百万ドルに拡大し、予測期間中に年平均4.5%で成長すると予想しています。本書では、血漿分画用コールドチェーン製品の世界市場について調査し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、種類別（超低温冷凍庫、血漿冷凍庫、温度監視装置、コンタクトショック血漿冷凍庫、その他）分析、エンドユーザー別（採血センター・血液成分供給業者、病院・輸血センター、臨床研究所、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ）分析、競争状況、企業情報などの内容を掲載しています。また、参入企業情報として、Blue Star Limited（India）、Thermo Fisher Scientific（US）、Godrej and Boyce Manufacturing Co. Ltd.（India）、Haier Biomedical（China）などが含まれています。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・世界の血漿分画用コールドチェーン製品市場規模：種類別
- 超低温冷凍庫の市場規模
- 血漿冷凍庫の市場規模
- 温度監視装置の市場規模
- コンタクトショック血漿冷凍庫の市場規模
- その他種類の市場規模
・世界の血漿分画用コールドチェーン製品市場規模：エンドユーザー別
- 採血センター・血液成分供給業者における市場規模
- 病院・輸血センターにおける市場規模
- 臨床研究所における市場規模
- その他エンドユーザーにおける市場規模
・世界の血漿分画用コールドチェーン製品市場規模：地域別
- 北米の血漿分画用コールドチェーン製品市場規模
- ヨーロッパの血漿分画用コールドチェーン製品市場規模
- アジア太平洋の血漿分画用コールドチェーン製品市場規模
- 中南米の血漿分画用コールドチェーン製品市場規模
- 中東・アフリカの血漿分画用コールドチェーン製品市場規模
・競争状況
・企業情報

“血漿分画用コールドチェーン製品の世界市場は大きく成長すると推定”
2022年の5億6,900万米ドルから、2027年には7億1,100万米ドルに達し、予測期間中の年平均成長率（CAGR）は4.5%を示すと予測されています。コールドチェーン製品市場の拡大は、人獣共通感染症に対する懸念の高まり、多様な治療分野における免疫グロブリンやその他の血漿製品の利用拡大、血漿由来の医薬品に対する需要の高まりなど、さまざまな要因によってもたらされます。血漿冷凍庫をはじめとするコールドチェーン製品のニーズの高まりや、先進的な低温保存装置の採用により、コールドチェーン製品の業界は進歩する見込みです。こうした技術の進歩は、コールドチェーン製品分野全体の成長と発展に貢献しています。

“血漿分画用コールドチェーン製品市場では超低温フリーザー分野がトップシェア”
血漿分画用コールドチェーン製品市場は、超低温フリーザー、プラズマフリーザー、温度モニタリング装置、プラズマコンタクトショックフリーザー、血液輸送ボックス、アイスラインド冷蔵庫、その他の7種類に分類されます。2021年の血漿分画用コールドチェーン製品の世界シェアでは、超低温フリーザー分野が最も高いシェアを占めています。血漿由来の医薬品に対する需要の増加、血漿分画技術の進歩、コールドチェーンインフラに対するニーズの高まりなどが、予測期間を通じて市場拡大を促進すると予想される要因のすべてです。

“2021年の血漿分画用コールドチェーン製品市場では、採血センターと血液成分プロバイダーが最も急成長しているセグメントを占める”
血漿分画用コールドチェーン製品市場は、エンドユーザーに基づいて、採血センターおよび血液成分プロバイダー、病院および輸血センター、臨床研究所、その他に分けられます。2021年、血漿分画用コールドチェーン製品の市場シェアは、採血センターおよび血液成分プロバイダーが最も高く、血漿分画に対する需要の高まり、血液媒介疾患に対する意識の高まりとスクリーニング、医療インフラの拡大などが、この市場の大きな割合を占める要因の一部です。

“予測期間中、中南米が最速の成長を遂げる見込み”
予測期間において、血漿分画用コールドチェーン製品市場のラテンアメリカは、地域別で最も速い成長が見られます。病院や医療施設の数が多いこと、免疫不全、血友病、自己免疫疾患などの慢性疾患の蔓延が拡大していることが、市場の成長を促す主な要因です。中南米ではこれらの疾病が増加しているため、重要な医療資源を保存するための血漿冷凍・冷蔵庫の必要性が高まっています。医療ニーズの高まり、治療法の進歩、血漿をベースとした製品の利点に対する理解の高まりを受けて、ラテンアメリカの血漿分画部門は拡大しています。この拡大により、血漿冷凍庫や冷蔵庫などの適切な保存装置の必要性が高まっています。

以下は、本調査が参照する血漿分画用コールドチェーン製品市場の主要企業（供給側）のリストです：
企業タイプ別 ティア1- 34%、ティア2- 46%、ティア3- 20％
役職別 Cレベル- 35%、ディレクターレベル- 25%、その他- 40％
地域別 北米-30%、欧州-45%、アジア太平洋地域-20%、中南米-3%、中東・アフリカ-2％

血漿分画用コールドチェーン製品の市場における主要企業には、B Medical Systems (US), Blue Star Limited (India), Thermo Fisher Scientific (US), Godrej and Boyce Manufacturing Co. Ltd. (India), Haier Biomedical (China), Eppendorf SE (Germany), Avantor, Inc. (US), Biolife Solutions Inc. (US), and Helmer Scientific Inc. (US)です。

調査範囲
この調査レポートは、コールドチェーン製品の主要市場セグメントを分析しています。本調査の目的は、タイプ、エンドユーザー、地域別に複数のカテゴリーにわたって市場規模と成長の可能性を推定することです。また、主要市場参入企業の徹底的な競合分析、企業プロフィール、製品やサービスの提供に関する主要な洞察、最近の進歩、主要な市場戦略も併せて掲載しています。

レポート購入の主な利点
この調査レポートは、コールドチェーン製品市場の近似値やセグメントに関するデータを提供しており、市場リーダーや新規参入者にとって有益です。本調査は、利害関係者が競争環境を理解し、事業のより良い位置づけのための洞察を得て、適切な市場参入戦略を策定するのに役立ちます。また利害関係者が市場動向を洞察し、主な促進要因、阻害要因、機会、問題点を知る上でも役立ちます。

本レポートでは、以下のポイントに関する洞察を提供しています：
血漿分画用コールドチェーン製品市場の成長に影響を与える主な促進要因（様々な治療領域における免疫グロブリンやその他の血漿製品の使用増加、血漿由来医薬品の需要増加、冷凍機器・システムの技術進歩）、機会（血漿分画センターの需要、コールドチェーンインフラ開発に対する政府の支援）、課題（訓練された人材の不足と機器を維持するための限られたリソース、厳しい政府規制、温室効果ガス排出に関する環境問題）分析

製品開発/イノベーション：
血漿分画用コールドチェーン製品市場の新技術、研究開発イニシアティブ、製品・サービス発表に関する包括的な詳細情報

市場開発：
魅力的な市場に関する総合データ、世界の血漿分画用コールドチェーン製品市場を分析した調査報告

市場の多様化：
血漿分画用コールドチェーン製品市場の新興製品・サービス、未開拓地域、現在の動向、投資に関する詳細情報

競合他社の評価：
B Medical Systems (US), Blue Star Limited (India), Thermo Fisher Scientific (US), Godrej and Boyce Manufacturing Co. Ltd. (India), Haier Biomedical (China), Eppendorf SE (Germany), Avantor, Inc. (US), Biolife Solutions Inc. (US), and Helmer Scientific Inc. (US)など、主要企業の市場シェア、成長計画、およびサービス提供の包括的な分析

❖ レポートの目次 ❖

1 INTRODUCTION 22
1.1 STUDY OBJECTIVES 22
1.2 MARKET DEFINITION 22
1.2.1 INCLUSIONS AND EXCLUSIONS 22
1.3 MARKET SCOPE 23
FIGURE 1 COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION SEGMENTATION 23
FIGURE 2 COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY REGION 23
1.3.1 YEARS CONSIDERED 24
1.4 CURRENCY CONSIDERED 24
1.5 STAKEHOLDERS 25
2 RESEARCH METHODOLOGY 26
2.1 RESEARCH APPROACH 26
FIGURE 3 RESEARCH DESIGN 26
2.1.1 SECONDARY DATA 27
2.1.1.1 Key data from secondary sources 27
2.1.2 PRIMARY DATA 28
FIGURE 4 PRIMARY SOURCES 28
2.1.2.1 Key data from primary sources 29
2.1.2.2 Key industry insights 30
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 30
2.2 MARKET SIZE ESTIMATION 31
FIGURE 6 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 31
FIGURE 7 REVENUE SHARE ANALYSIS ILLUSTRATION: THERMO FISHER SCIENTIFIC (US) 32
FIGURE 8 SUPPLY-SIDE ANALYSIS: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION (2021) 32
FIGURE 9 COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION: BOTTOM-UP APPROACH 33
FIGURE 10 DRIVERS, OPPORTUNITIES, AND CHALLENGES (2022–2027): IMPACT ON MARKET GROWTH AND CAGR 34
FIGURE 11 CAGR PROJECTIONS 34
FIGURE 12 TOP-DOWN APPROACH 35
2.3 LIMITATIONS 35
2.3.1 METHODOLOGY-RELATED LIMITATIONS 36
2.3.2 MARKET BREAKDOWN & DATA TRIANGULATION 36
FIGURE 13 MARKET DATA TRIANGULATION METHODOLOGY 36
2.4 MARKET SHARE ANALYSIS 37
2.5 STUDY ASSUMPTIONS 37
2.6 RISK ASSESSMENT 38
2.7 RECESSION IMPACT ANALYSIS 38
3 EXECUTIVE SUMMARY 39
FIGURE 14 COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2022 VS. 2027 (USD MILLION) 39
FIGURE 15 COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2022 VS. 2027 (USD MILLION) 40
FIGURE 16 COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION: GEOGRAPHIC SNAPSHOT 41
4 PREMIUM INSIGHTS 42
4.1 COLD CHAIN PRODUCTS FOR PLASMA FRACTIONATION: MARKET OVERVIEW 42
FIGURE 17 RISING USE OF IMMUNOGLOBULINS AND OTHER PLASMA PRODUCTS TO DRIVE MARKET GROWTH 42
4.2 ASIA PACIFIC: COLD CHAIN PRODUCTS FOR PLASMA FRACTIONATION, BY TYPE & COUNTRY (2021) 43
FIGURE 18 ULTRA-LOW-TEMPERATURE FREEZERS TO HOLD LARGEST MARKET SHARE 43
4.3 COLD CHAIN PRODUCTS FOR PLASMA FRACTIONATION: GEOGRAPHIC GROWTH OPPORTUNITIES 44
FIGURE 19 CHINA TO REGISTER HIGHEST GROWTH OVER FORECAST PERIOD 44
4.4 COLD CHAIN PRODUCTS FOR PLASMA FRACTIONATION: GEOGRAPHIC MIX 44
FIGURE 20 NORTH AMERICA TO DOMINATE MARKET OVER FORECAST PERIOD 44
4.5 COLD CHAIN PRODUCTS FOR PLASMA FRACTIONATION: DEVELOPING VS. DEVELOPED COUNTRIES 45
FIGURE 21 DEVELOPING COUNTRIES TO PRESENT GROWTH OPPORTUNITIES TO MARKET PLAYERS DURING THE FORECAST PERIOD 45
5 MARKET OVERVIEW 46
5.1 INTRODUCTION 46
5.2 MARKET DYNAMICS 46
FIGURE 22 COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 46
5.2.1 DRIVERS 46
5.2.1.1 Rising use of immunoglobulins and other plasma products 46
FIGURE 23 WORLDWIDE POLYVALENT IMMUNE GLOBULIN SALES FROM 2010 TO 2026 47
5.2.1.2 Increasing demand for plasma-derived medicinal products to treat chronic diseases 47
TABLE 1 PLASMA-DERIVED MEDICINAL PRODUCTS AND THEIR CLINICAL INDICATIONS 48
5.2.1.3 Technological advancements in refrigeration equipment and systems 48
5.2.2 OPPORTUNITIES 49
5.2.2.1 Demand for plasma fractionation centers 49
FIGURE 24 PLASMA FRACTIONATION PLANTS WORLDWIDE (2018) 49
5.2.2.2 Government support for cold chain infrastructure development 50
5.2.3 CHALLENGES 50
5.2.3.1 Shortage of trained manpower and limited resources to maintain equipment 50
5.2.3.2 Stringent government regulations 50
5.2.3.3 Environmental concerns regarding greenhouse gas emissions 51
5.3 PRICING ANALYSIS 51
5.3.1 AVERAGE SELLING PRICE OF COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE 51
TABLE 2 AVERAGE SELLING PRICE OF COLD CHAIN PRODUCTS, BY TYPE (USD) 51
5.3.2 AVERAGE SELLING PRICE TRENDS 52
5.4 SUPPLY CHAIN ANALYSIS 52
FIGURE 25 SUPPLY CHAIN ANALYSIS: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION 52
5.5 ECOSYSTEM ANALYSIS 53
FIGURE 26 ECOSYSTEM ANALYSIS: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION 54
5.6 PATENT ANALYSIS 54
FIGURE 27 PATENT PUBLICATION TRENDS (JANUARY 2013–MARCH 2023) 54
FIGURE 28 TOP APPLICANTS (COMPANIES/INSTITUTES) FOR COLD CHAIN PRODUCTS FOR PLASMA FRACTIONATION PATENTS (2013–2023) 55
5.7 VALUE CHAIN ANALYSIS 55
FIGURE 29 VALUE CHAIN ANALYSIS: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION 56
5.8 TECHNOLOGY ANALYSIS 56
5.8.1 KEY TECHNOLOGY 56
5.8.1.1 Ultra-low freezer technology 56
5.8.2 ADJACENT TECHNOLOGY 57
5.8.2.1 Cryopreservation 57
5.9 REGULATORY LANDSCAPE 57
5.9.1 REGULATORY ANALYSIS 57
5.9.1.1 North America 57
5.9.1.2 Europe 58
5.9.1.3 Asia Pacific 58
5.9.1.4 Latin America 59
5.9.1.5 Middle East and Africa 59
5.9.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATION 60
TABLE 3 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 60
TABLE 4 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 61
TABLE 5 ASIA PACIFIC AND ROW: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 62
5.10 PORTER’S FIVE FORCES ANALYSIS 62
TABLE 6 PORTER’S FIVE FORCES ANALYSIS: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION 62
5.10.1 INTENSITY OF COMPETITIVE RIVALRY 63
5.10.2 BARGAINING POWER OF SUPPLIERS 63
5.10.3 BARGAINING POWER OF BUYERS 63
5.10.4 THREAT OF NEW ENTRANTS 63
5.10.5 THREAT OF SUBSTITUTES 64
5.11 KEY CONFERENCES AND EVENTS, 2023–2024 64
TABLE 7 COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION: KEY CONFERENCES AND EVENTS, 2023–2024 64
5.12 KEY STAKEHOLDERS AND BUYING CRITERIA 65
5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS 65
FIGURE 30 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF COLD CHAIN PRODUCTS FOR PLASMA FRACTIONATION 65
TABLE 8 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE TYPES OF COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION 65
5.12.2 BUYING CRITERIA 66
TABLE 9 KEY BUYING CRITERIA FOR TOP THREE TYPES OF COLD CHAIN PRODUCTS FOR PLASMA FRACTIONATION 66
5.13 TRADE ANALYSIS 67
TABLE 10 EXPORTS OF COLD CHAIN STORAGE LABORATORY EQUIPMENT (2022) 67
TABLE 11 IMPORTS OF COLD CHAIN STORAGE LABORATORY EQUIPMENT (2022) 68
5.14 COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION: RECESSION IMPACT 69
6 COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE 70
6.1 INTRODUCTION 71
TABLE 12 COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION) 71
TABLE 13 COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY COUNTRY, 2020–2027 (USD MILLION) 72
6.2 ULTRA-LOW-TEMPERATURE FREEZERS 72
6.2.1 RISING DEMAND IN PLASMA STORAGE APPLICATIONS TO DRIVE MARKET GROWTH 72
TABLE 14 ULTRA-LOW-TEMPERATURE FREEZERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 73
6.3 PLASMA FREEZERS 74
6.3.1 RISING DEMAND IN SCIENTIFIC AND THERAPEUTIC APPLICATIONS TO BOOST GROWTH 74
TABLE 15 PLASMA FREEZERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 74
6.4 TEMPERATURE MONITORING DEVICES 75
6.4.1 ADOPTION OF NOVEL TECHNOLOGIES IN TEMPERATURE MONITORING DEVICES TO PROPEL MARKET 75
TABLE 16 TEMPERATURE MONITORING DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 76
6.5 PLASMA CONTACT SHOCK FREEZERS 76
6.5.1 NEED FOR RAPID FREEZING IN PLASMA TRANSPORT TO DRIVE MARKET 76
TABLE 17 PLASMA CONTACT SHOCK FREEZERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 77
6.6 BLOOD TRANSPORT BOXES 77
6.6.1 RISING ADOPTION OF TEMPERATURE-CONTROLLED BOXES TO TRANSPORT PLASMA FRACTIONATED COMPOUNDS TO DRIVE MARKET 77
TABLE 18 BLOOD TRANSPORT BOXES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 78
6.7 ICE-LINED REFRIGERATORS 78
6.7.1 COST-EFFECTIVENESS TO PROPEL END-USER ADOPTION 78
TABLE 19 ICE-LINED REFRIGERATORS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 79
6.8 OTHER PRODUCTS 79
TABLE 20 OTHER COLD CHAIN PRODUCTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 80
7 COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER 81
7.1 INTRODUCTION 82
TABLE 21 COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION) 82
7.2 BLOOD COLLECTION CENTERS & BLOOD COMPONENT PROVIDERS 82
7.2.1 RISING DEMAND FOR PLASMA-DERIVED PRODUCTS TO DRIVE MARKET GROWTH 82
TABLE 22 COLD CHAIN PRODUCTS MARKET FOR BLOOD COLLECTION CENTERS & BLOOD COMPONENT PROVIDERS, BY COUNTRY, 2020–2027 (USD MILLION) 83
7.3 HOSPITALS & TRANSFUSION CENTERS 83
7.3.1 NEED TO ENSURE SAFE COLLECTION, STORAGE, AND COLD CHAIN MANAGEMENT OF PLASMA TO DRIVE MARKET GROWTH 83
TABLE 23 COLD CHAIN PRODUCTS MARKET FOR HOSPITALS & TRANSFUSION CENTERS, BY COUNTRY, 2020–2027 (USD MILLION) 84
7.4 CLINICAL RESEARCH LABORATORIES 84
7.4.1 ROLE OF LABS IN PLASMA FRACTIONATION AND COLD CHAIN PRODUCT DEVELOPMENT TO BOOST MARKET GROWTH 84
TABLE 24 COLD CHAIN PRODUCTS MARKET FOR CLINICAL RESEARCH LABORATORIES, BY COUNTRY, 2020–2027 (USD MILLION) 85
7.5 OTHER END USERS 85
TABLE 25 COLD CHAIN PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2020–2027 (USD MILLION) 86
8 COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY REGION 87
8.1 INTRODUCTION 88
FIGURE 31 COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION: GEOGRAPHIC GROWTH OPPORTUNITIES 88
TABLE 26 COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY REGION, 2020–2027 (USD MILLION) 89
8.2 NORTH AMERICA 89
8.2.1 NORTH AMERICA: RECESSION IMPACT 89
FIGURE 32 NORTH AMERICA: LABORATORY FREEZERS MARKET SNAPSHOT 90
TABLE 27 NORTH AMERICA: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY COUNTRY, 2020–2027 (USD MILLION) 90
TABLE 28 NORTH AMERICA: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION) 91
TABLE 29 NORTH AMERICA: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION) 91
8.2.2 US 92
8.2.2.1 US to hold largest share of North American market 92
TABLE 30 US: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION) 92
TABLE 31 US: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION) 93
8.2.3 CANADA 93
8.2.3.1 Growing pharma R&D and increasing use of plasma-derived compounds to boost market 93
TABLE 32 CANADA: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION) 94
TABLE 33 CANADA: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION) 94
8.3 EUROPE 95
8.3.1 EUROPE: RECESSION IMPACT 95
TABLE 34 EUROPE: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY COUNTRY, 2020–2027 (USD MILLION) 95
TABLE 35 EUROPE: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION) 96
TABLE 36 EUROPE: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION) 96
8.3.2 GERMANY 97
8.3.2.1 Germany to dominate European market 97
TABLE 37 GERMANY: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION) 97
TABLE 38 GERMANY: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION) 98
8.3.3 FRANCE 98
8.3.3.1 Growing biotech & pharma industry and high prevalence of bleeding disorders to drive market 98
TABLE 39 FRANCE: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION) 99
TABLE 40 FRANCE: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION) 99
8.3.4 UK 100
8.3.4.1 Rising incidence of hemophilia and growing consumption of coagulation factors to propel market 100
TABLE 41 UK: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION) 100
TABLE 42 UK: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION) 101
8.3.5 ITALY 101
8.3.5.1 Strong pharma sector and rising geriatric population to support market 101
TABLE 43 ITALY: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION) 102
TABLE 44 ITALY: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION) 102
8.3.6 SPAIN 103
8.3.6.1 Rising chronic disease prevalence to boost demand 103
TABLE 45 SPAIN: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION) 103
TABLE 46 SPAIN: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION) 104
8.3.7 REST OF EUROPE 104
TABLE 47 REST OF EUROPE: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION) 105
TABLE 48 REST OF EUROPE: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION) 105
8.4 ASIA PACIFIC 106
8.4.1 ASIA PACIFIC: RECESSION IMPACT 106
FIGURE 33 APAC: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION SNAPSHOT 107
TABLE 49 ASIA PACIFIC: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY COUNTRY, 2020–2027 (USD MILLION) 108
TABLE 50 ASIA PACIFIC: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION) 108
TABLE 51 ASIA PACIFIC: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION) 109
8.4.2 CHINA 109
8.4.2.1 China to dominate Asia Pacific market 109
TABLE 52 CHINA: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION) 110
TABLE 53 CHINA: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION) 110
8.4.3 JAPAN 111
8.4.3.1 Growing aging population and rising prevalence of neurological disorders to propel growth 111
TABLE 54 JAPAN: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION) 111
TABLE 55 JAPAN: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION) 112
8.4.4 INDIA 112
8.4.4.1 Growing pharma-biotech industry to drive demand 112
TABLE 56 INDIA: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION) 113
TABLE 57 INDIA: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION) 113
8.4.5 SOUTH KOREA 114
8.4.5.1 Rising awareness, advancements in medical treatments, and aging population to drive market 114
TABLE 58 SOUTH KOREA: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION) 114
TABLE 59 SOUTH KOREA: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION) 115
8.4.6 AUSTRALIA 115
8.4.6.1 Rising demand for plasma products to treat chronic diseases to propel market 115
TABLE 60 AUSTRALIA: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION) 116
TABLE 61 AUSTRALIA: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION) 116
8.4.7 REST OF ASIA PACIFIC 117
TABLE 62 REST OF ASIA PACIFIC: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION) 117
TABLE 63 REST OF ASIA PACIFIC: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION) 118
8.5 LATIN AMERICA 118
8.5.1 RISING INVESTMENTS IN BRAZIL AND GROWING DISEASE PREVALENCE ACROSS LATAM TO BOOST MARKET 118
8.5.2 LATIN AMERICA: RECESSION IMPACT 118
TABLE 64 LATIN AMERICA: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION) 119
TABLE 65 LATIN AMERICA: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION) 119
8.6 MIDDLE EAST & AFRICA 120
8.6.1 INFRASTRUCTURAL DEVELOPMENT IN HEALTHCARE TO OFFER GROWTH OPPORTUNITIES 120
8.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT 120
TABLE 66 MIDDLE EAST & AFRICA: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION) 121
TABLE 67 MIDDLE EAST & AFRICA: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION) 121
9 COMPETITIVE LANDSCAPE 122
9.1 OVERVIEW 122
9.2 KEY PLAYER STRATEGIES 122
TABLE 68 OVERVIEW OF STRATEGIES ADOPTED BY MAJOR PLAYERS IN COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION 123
9.3 REVENUE SHARE ANALYSIS FOR KEY PLAYERS IN COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION 124
FIGURE 34 REVENUE ANALYSIS FOR KEY PLAYERS IN COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION MARKET 124
9.4 MARKET SHARE ANALYSIS 125
FIGURE 35 COLD CHAIN PRODUCTS FOR PLASMA FRACTIONATION: MARKET SHARE ANALYSIS, BY KEY PLAYER, 2021 125
TABLE 69 COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION: DEGREE OF COMPETITION 126
FIGURE 36 R&D ASSESSMENT OF KEY PLAYERS 127
9.5 COMPANY EVALUATION QUADRANT (KEY COMPANIES), 2021 127
9.5.1 STARS 127
9.5.2 PERVASIVE PLAYERS 127
9.5.3 EMERGING LEADERS 127
9.5.4 PARTICIPANTS 128
FIGURE 37 COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION: COMPANY EVALUATION MATRIX, 2021 128
9.6 COMPETITIVE BENCHMARKING 129
TABLE 70 OVERALL COMPANY FOOTPRINT 129
TABLE 71 COMPANY FOOTPRINT ANALYSIS, BY TYPE 130
TABLE 72 COMPANY FOOTPRINT ANALYSIS, BY END USER 131
TABLE 73 COMPANY FOOTPRINT ANALYSIS, BY REGION 132
9.7 COMPETITIVE SCENARIO 133
9.7.1 PRODUCT LAUNCHES & APPROVALS 133
TABLE 74 PRODUCT LAUNCHES & APPROVALS, JANUARY 2019–MARCH 2023 133
9.7.2 DEALS 134
TABLE 75 DEALS, JANUARY 2021–MARCH 2023 134
9.7.3 OTHER DEVELOPMENTS 134
TABLE 76 OTHER DEVELOPMENTS, JANUARY 2019– MARCH 2023 134
10 COMPANY PROFILES 135
(Business overview, Products offered, Recent Developments, MNM view)*
10.1 KEY PLAYERS 135
10.1.1 THERMO FISHER SCIENTIFIC, INC. 135
TABLE 77 THERMO FISHER SCIENTIFIC: BUSINESS OVERVIEW 135
FIGURE 38 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT 136
10.1.2 HAIER BIOMEDICAL (HAIER GROUP) 139
TABLE 78 HAIER BIOMEDICAL: BUSINESS OVERVIEW 139
FIGURE 39 HAIER BIOMEDICAL (HAIER GROUP): COMPANY SNAPSHOT (2021) 140
10.1.3 EPPENDORF SE 143
TABLE 79 EPPENDORF AG: BUSINESS OVERVIEW 143
FIGURE 40 EPPENDORF AG: COMPANY SNAPSHOT 144
10.1.4 B MEDICAL SYSTEMS (AZENTA) 147
TABLE 80 B. MEDICAL SYSTEM (AZENTA): BUSINESS OVERVIEW 147
FIGURE 41 B MEDICAL SYSTEMS (AZENTA): COMPANY SNAPSHOT (2021) 148
10.1.5 BLUE STAR LIMITED 150
TABLE 81 BLUE STAR LIMITED: BUSINESS OVERVIEW 150
FIGURE 42 BLUE STAR LIMITED: COMPANY SNAPSHOT 151
TABLE 82 BLUE STAR LIMITED: PRODUCTS OFFERED 151
10.1.6 AVANTOR, INC. 153
TABLE 83 AVANTOR, INC.: BUSINESS OVERVIEW 153
FIGURE 43 AVANTOR, INC.: COMPANY SNAPSHOT 154
10.1.7 GODREJ AND BOYCE MANUFACTURING CO. LTD. 156
TABLE 84 GODREJ AND BOYCE MANUFACTURING CO. LTD.: BUSINESS OVERVIEW 156
FIGURE 44 GODREJ AND BOYCE MANUFACTURING CO. LTD.: COMPANY SNAPSHOT 156
10.1.8 BIOLIFE SOLUTIONS 158
TABLE 85 BIOLIFE SOLUTIONS: BUSINESS OVERVIEW 158
FIGURE 45 BIOLIFE SOLUTIONS: COMPANY SNAPSHOT 159
10.1.9 HELMER SCIENTIFIC 161
TABLE 86 HELMER SCIENTIFIC: BUSINESS OVERVIEW 161
10.1.10 VESTFROST SOLUTIONS A/S 164
TABLE 87 VESTFROST SOLUTIONS A/S: BUSINESS OVERVIEW 164
10.1.11 JEIO TECH INC. 165
TABLE 88 JEIO TECH INC.: BUSINESS OVERVIEW 165
10.1.12 DEEPEE COOLING PRODUCTS 166
TABLE 89 DEEPEE COOLING PRODUCTS: BUSINESS OVERVIEW 166
10.1.13 BERLINGER & CO. AG 167
TABLE 90 BERLINGER & CO. AG: BUSINESS OVERVIEW 167
10.1.14 MONNIT CORPORATION 169
TABLE 91 MONNIT CORPORATION: BUSINESS OVERVIEW 169
10.1.15 ZHEJIANG HELI REFRIGERATION EQUIPMENT CO. LTD. 171
TABLE 92 ZHEJIANG HELI REFRIGERATION EQUIPMENT CO. LTD.: BUSINESS OVERVIEW 171
*Details on Business overview, Products offered, Recent Developments, MNM view might not be captured in case of unlisted companies.
10.2 OTHER PLAYERS 173
10.2.1 QINGDAO CAREBIOS BIOLOGICAL TECHNOLOGY CO., LTD 173
10.2.2 EBAC CO., LTD. 174
10.2.3 BIOTECNO 175
10.2.4 ZHONGKE MEILING CRYOGENICS CO., LTD. 176
10.2.5 BIONICS SCIENTIFIC TECHNOLOGIES (P) LTD. 177
10.2.6 STERICOX INDIA PRIVATE LIMITED 178
10.2.7 ENVIRO TECHNOLOGIES 179
10.2.8 WITHNELL SENSORS 179
10.2.9 TECNOSOFT SRL 180
10.2.10 PHILIPP KIRSCH GMBH 181
11 APPENDIX 183
11.1 DISCUSSION GUIDE 183
11.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 187
11.3 RELATED REPORTS 189
11.4 AUTHOR DETAILS 190



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 血漿分画用コールドチェーン製品の世界市場予測（〜2027年）：種類別、エンドユーザー別(Cold Chain Products Market for Plasma Fractionation by Type (Ultra-low temperature freezer, Plasma freezer, Temperature monitoring devices, Plasma contact shock freezer, Blood transport boxes, Ice-lined refrigerator), End User - Global Forecast to 2027)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 血漿分画の世界市場2023年～2030年：製品別、方法別、用途別、エンドユーザー別、地域別
  • 血漿分画の世界市場予測（～2028）：製品別、用途別、エンドユーザー別
  • 血漿分画の世界市場2022：アルブミン、免疫グロブリン、凝固因子、その他

    • ◆H&Iグローバルリサーチのお客様（例）◆